Jincheng Pharmaceutical: Nearly 13 tons of nicotine for e-cigarettes expected to be shipped in June

On July 25, Jincheng Pharmaceutical stated on an interactive investor platform that the company’s nicotine for e-cigarettes has entered mass production and sales have been strong. It is expected to complete shipments for nearly 13 tons of orders in June and July. The company will expand production in line with the newly approved production capacity issued by the State Tobacco Monopoly Administration, while stepping up market promotion and sales efforts.

Previously, on the evening of July 16, Jincheng Pharmaceutical announced that its wholly owned subsidiary, Shandong Jincheng Pharmaceutical Chemical Co., Ltd., had recently received the Tobacco Monopoly Production Enterprise License (nicotine production enterprise for e-cigarettes) issued by the State Tobacco Monopoly Administration. In addition to domestic sales, the approved business scope now also includes exports, and the validity period has been extended to June 30, 2025.